<http://schema.org/description>
"Peregrine Pharmaceuticals recently received encouraging news when the company announced that the FDA has agreed on the design for the phase III registration trial for its oncology candidate, bavituximab"^^<http://www.w3.org/2001/XMLSchema#string>
<https://www.zacks.com/stock/news/100094/encouraging-news-for-peregrine-pharma>